La supervivencia a cinco años por Cáncer de Colon en los años ´70 se situaba en torno al 50%, mientras que hoy casi alcanza el 65%. Es decir, una ganancia de supervivencia de casi un 1% cada dos años. Quizá puede parecer insignificante año a año, pero si consideramos que cada año se diagnostican en España unos 30.000 casos de este tumor, la supervivencia a cinco años ha pasado de ser privilegio de 15.000 pacientes a 19.500 (¡4.500 pacientes más que si estos avances no hubieran tenido lugar!).
El 9,2% de los españoles puede sufrir una enfermedad renal crónica y un 6,8% puede progresar hacia insuficiencia renal. Son más proclives las poblaciones “de riesgo”: diabéticos, hipertensos y pacientes con insuficiencia cardíaca
Los productos de radiografía digital inalámbricos de Canon mejoran la experiencia global de los pacientes al permitir que los profesionales médicos completen más rápidamente sus consultas, gracias a la rápida previsualización en todos los dispositivos de la gama. Los dispositivos están también equipados con el software de control CXDI NE de Canon, que reduce el número de pasos necesarios para capturar una imagen de rayos X.
Interventional radiologists have devised a new way to access a woman s fibroids—by flipping her wrist and treating via an arm not groin artery—to nonsurgically shrink noncancerous growths in the muscular wall of the uterus. Researchers found this to be less painful and traumatic for women, allowing them to immediately sit up and move after uterine fibroid embolization (UFE)—with no overnight stay, according to a March article in the Society of Interventional Radiology s flagship publication, the Journal of Vascular and Interventional Radiology.
A screening program for abdominal aortic aneurysms, integrated into an electronic health record, dramatically reduced the number of unscreened at-risk men by more than 50 percent within 15 months, according to a Kaiser Permanente study published in the Journal of Vascular Surgery. An abdominal aortic aneurysm is a balloon- like bulge in the aorta, which - if ruptured - can result in death. It is estimated that more than one million Americans are living with undiagnosed AAA, according to the Society for Vascular Surgery.
Temple University Hospital (TUH) could be among the first U.S.-based hospitals to test a new device known as a multilayer stent in patients suffering from aortic aneurysm, a condition characterized by the formation of a potentially life-threatening bulge in the aorta. Approved in Europe in 2010, the device has already been used to help hundreds of European patients with the condition, and Grayson H. Wheatley III, MD, FACS, Associate Professor of Surgery at Temple University School of Medicine, and Director of Aortic & Endovascular Surgery at TUH, thinks thousands more could benefit in the United States.
EKOS Corporation, a BTG International group company, located in Bothell, Washington in the United States, has announced the publication of the results of its Ultrasound Accelerated Thrombolysis of Pulmonary Embolism (PE) trial (ULTIMA) in the peer-reviewed journal of the American Heart Association, CIRCULATION. The announcement was made at The International Symposium on Endovascular Therapy (ISET) in Miami, Florida in the United States. The ULTIMA study is the world s first and only prospective randomized controlled clinical trial of patients with submassive PE treated with either standard of care intravenous anticoagulation or the EKOS EkoSonic® Endovascular System and rt-PA (Actilyse®, Boehringer Ingelheim). EKOS unique technology uses ultrasound to accelerate the action of clot-dissolving drugs. Dr. Nils Kucher, Director of the Venous Thromboembolism Research Group at the University Hospital in Bern, Switzerland, is the lead author and principal investigator of the ULTIMA study.
You might think building muscle is a good thing, but that s often not so in the case of blood vessels in adults. In fact, excess smooth muscle is a root problem in many vascular diseases, as it causes arteries to constrict and blood pressure to rise. Now, an in-depth analysis of arterioles in mice with pulmonary hypertension explains how those misplaced smooth muscle cells develop.
Early but not advanced forms of atherosclerotic plaques in the vessel wall disappear when the levels of bad cholesterol are lowered, according to a study in mice from Karolinska Institutet, Sweden. The findings, published in PLoS Genetics, indicate that preventative cholesterol-lowering treatment could prevent more advanced, clinically relevant plaque to develop.
Scientific Statement from American Heart Association details latest evidence for diagnosis and treatment A vascular disease called fibromuscular dysplasia, which can cause high blood pressure, kidney failure, stroke and other symptoms -- mostly in women -- is poorly understood by many healthcare providers, according to a Scientific Statement from the American Heart Association.
Research from The Shiley Center for Orthopaedic Research and Education at Scripps Clinic could change how patients are treated to prevent blood clots after joint replacement surgery. A study recently published as the lead article in the Journal of Bone and Joint Surgery determined that after lower extremity joint replacement surgery a mobile compression device was just as effective as blood thinners in preventing deep vein thrombosis (DVT), but without negative side effects including bleeding complications.
In collaboration with an international team, researchers at Karolinska Institutet in Sweden have developed an antibody, 3F7, which blocks a protein that is active in the coagulation system factor XII. Inhibition of factor XII makes it possible to prevent thrombosis in blood vessels without increasing the risk of bleeding in clinical settings.
CeloNova has announced the US FDA 510(k) clearance expanding the indication for Embozene microspheres to include the treatment of uterine fibroids.
The European Congress of Radiology (ECR), the annual meeting of the European Society of Radiology (ESR) was held 6–10 March, Vienna, Austria.
A retrospective study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9% decrease in body weight, three months after the procedure. Could embolization of the left gastric artery be used in the treatment of obesity?
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos